Literature DB >> 2982405

The effect of 2'-fluoro-2'-deoxycytidine on herpes virus growth.

F Wohlrab, A T Jamieson, J Hay, R Mengel, W Guschlbauer.   

Abstract

The effect of 2'-fluoro-2'-deoxycytidine (dCfl) on the growth of certain viruses of the herpes type was investigated. It is shown that the compound has considerable anti-viral activity against HSV-I, HSV-II, pseudorabies virus and equine abortion virus. It has an effect comparable to that of araC and is more efficient than br5dC, but less so than acyclovir. Experiments with thymidine kinase-negative strains of HSV-I indicated that dCfl was phosphorylated by the viral kinase, and its Km appears to be low and close to that of thymidine. Density gradient centrifugation enabled us to show that dCfl was incorporated into cellular and viral DNA and RNA. The cytotoxic activity of dCfl appears to be about 10-times smaller than that of araC. Removal of the nucleoside analog, washing and replacement with deoxycytidine reversed this effect, indicating rather a cytostatic than cytotoxic effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982405     DOI: 10.1016/0167-4781(85)90053-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.

Authors:  Yohichi Kumaki; Craig W Day; Donald F Smee; John D Morrey; Dale L Barnard
Journal:  Antiviral Res       Date:  2011-09-08       Impact factor: 5.970

2.  2'-fluoro-2'-deoxycytidine inhibits Borna disease virus replication and spread.

Authors:  Jeffrey J Bajramovic; Romain Volmer; Sylvie Syan; Sylvie Pochet; Daniel Gonzalez-Dunia
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 3.  Nucleosides for the treatment of respiratory RNA virus infections.

Authors:  Paul C Jordan; Sarah K Stevens; Jerome Deval
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

4.  Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2'-deoxy-2'-fluorocytidine.

Authors:  Lieven J Stuyver; Tamara R McBrayer; Tony Whitaker; Phillip M Tharnish; Mangala Ramesh; Stefania Lostia; Leanne Cartee; Junxing Shi; Ann Hobbs; Raymond F Schinazi; Kyoichi A Watanabe; Michael J Otto
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.